Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Francisco Alves, Inês F. Antunes, Emiliano Cazzola, Frederik Cleeren, Bart Cornelissen, Antonia Denkova, Jonathan Engle, Alain Faivre-Chauvet, Nic Gillings, Jeroen J.M.A. Hendrikx, Amir R. Jalilian, Nicholas P. van der Meulen, Renata Mikolajczak, Oliver C. Neels*, Maroor R.A. Pillai, Raymond Reilly, Sietske Rubow, Yann Seimbille, Sarah Spreckelmeyer, Wiktor SzymanskiCarlotta Taddei

*Corresponding author for this work

Research output: Contribution to journalReview articlePopular

10 Downloads (Pure)


Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry.

Original languageEnglish
Article number31
Pages (from-to)1-16
Number of pages16
JournalEJNMMI Radiopharmacy and Chemistry
Issue number1
Early online date8 Sept 2021
Publication statusPublished - Dec 2021

Bibliographical note

Funding Information:
Open Access funding enabled and organized by Projekt DEAL. Financial support from EJNMMI Radiopharmacy and Chemistry to make this review article available for Open Access is gratefully acknowledged.

Publisher Copyright:
© 2021, The Author(s).


Dive into the research topics of 'Highlight selection of radiochemistry and radiopharmacy developments by editorial board'. Together they form a unique fingerprint.

Cite this